Galmed Pharmaceuticals Ltd. (GLMD)

2.45
0.01 0.41
NASDAQ
Prev Close 2.46
Open 2.45
Day Low/High 2.43 / 2.49
52 Wk Low/High 2.15 / 6.25
Volume 46.85K
Exchange NASDAQ
Shares Outstanding 25.08B
Market Cap 61.46M
P/E Ratio 2.98
Div & Yield N.A. (N.A)

Galmed Soars on Encouraging Trial Results

Markets have perked up just a tad across the board since our last update. As mentioned in an earlier post, Galmed Pharmaceuticals is the second small-cap NASH (nonalcoholic steatohepatitis) play that has soared over the past week. The shares are up ...

These 2 Pharma Firms Target NASH

With roughly an hour to go before the market open, futures are fairly flat. NASH development has been in the headlines lately. Last week, Madrigal Pharmaceuticals  rocketed up in trading after disclosing encouraging mid-stage trial results. Today, i...

Shark Bites: Stock Picking Makes a Comeback

Shark Bites: Stock Picking Makes a Comeback

Market ends the week with some profit-taking.

I Am One of the Underinvested Bulls Right Now

I Am One of the Underinvested Bulls Right Now

It's challenging to put cash to work but I'll keep digging.

These Biotech Names Are on My Radar

These Biotech Names Are on My Radar

But I'm expecting that things will slow into the Fed news.